Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
OHRI stem cell transplant trial for multiple sclerosis profiled on national news
February 22, 2009
A
CTV W-Five documentary
about experimental stem cell therapies for multiple sclerosis featured a clinical trial led by Drs. Mark Freedman and Harry Atkins at OHRI. The trial is investigating whether stem cell therapy can be used to replace a patient's damaged immune system with a new, healthy one. Strong chemotherapy is used to destroy the existing immune system, and then purified bone marrow stem cells (taken previously from the same patient) are used to regenerate a new one.
For more information, please see this
press release
about the trial, or see the complete description of the trial on the website of the
MS Society of Canada
. The
Stem Cell Network
also provides general information on stem cell research for MS. Patients interested in experimental therapies for MS should speak with their specialists.